Progress in standardization of immunoassays for prostate-specific antigen

Urologic Clinics of North America

Volumn 24, Issue 2, 1997, Pages 269-273

  Stamey, T A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 2 MACROGLOBULIN; PROSTATE SPECIFIC ANTIGEN;

BLOOD LEVEL; CALIBRATION; FOOD AND DRUG ADMINISTRATION; FREEZE DRYING; HUMAN; IMMUNOASSAY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVIEW; SEMINAL PLASMA; STANDARDIZATION;

EID: 0030929802     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70372-4     Document Type: Article

References (19)

1. A. Be´langer H. van Halbeek H.C.B. Graves Molecular mass and carbohydrate structure of prostate specific antigen: Studies for establishment of an international PSA standard Prostate 27 1995 187 197
2. 1-antichymotrypsin as a DNA-binding protein from human serum Biochem Biophys Res Comm 95 1980 1737 1742
3. W.J. Catalona J.P. Richie F.R. Ahmann Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men J Urol 151 1994 1283 1290
4. Z. Chen A. Prestigiacomo T.A. Stamey Lyophilized PSA-ACT complex is stable Clin Chem 42 1996 1297
5. Z. Chen A. Prestigiacomo T.A. Stamey Purification and characterization of prostate specific antigen complexed to alpha-1-antichymotrypsin as a reference material for international standardization of PSA immunoassays Clin Chem 41 1995 1273 1282
6. A. Christensson C.B. Laurell H. Lilja Enzymatic activity of prostate-specific antigen and its reaction with extracellular serine proteinase inhibitors Eur J Biochem 194 1990 755 763
7. 1-antichymotrypsin as an indicator of prostate cancer J Urol 150 1993 100 105
8. D.W. Keetch G.L. Andriole Prostate cancer screening: What are physicians to do? What have we learned? Monographs In Urology 17 1996
9. 1-antichymotrypsin Clin Chem 37 1991 1618 1625
10. 1-antichymotrypsin complex Clin Chem 41 1995 1480 1488
11. A.F. Prestigiacomo T.A. Stamey Physiological variation of serum prostate specific antigen (PSA) in the 4.0–10.0 ng/mL range in male volunteers J Urol 155 1996 1977 1980
12. A.F. Prestigiacomo H. Lilja K. Pettersson A comparison of the “free” fraction of serum prostate specific antigen (PSA) in men with benign and cancerous prostates: The “best case” scenario J Urol 157 1997 189 194
13. H.-P. Schmid J.E. McNeal T.A. Stamey Observations on the doubling time of prostate cancer: The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume Cancer 71 1993 2031 2040
14. G.F. Sensabaugh E.T. Blake Seminal plasma protein p30: Simplified purification and evidence for identity with prostate-specific antigen J Urol 144 1990 1523 1526
15. T.A. Stamey Second Stanford Conference on International Standardization of Prostate-Specific Antigen Immunoassays: September 1 and 2, 1994 Urology 45 1995 173 184
16. 1-antichymotrypsin: influence of cancer volume, location and therapeutic selection of resistant clones J Urol 152 1994 1510 1514
17. T.A. Stamey A.F. Prestigiacomo Z. Chen Standardization of immunoassays for prostate specific antigen: A different view based on experimental observations Cancer 74 1994 1662 1666
18. T.A. Stamey D.B. Teplow H.C.B. Graves Identity of PSA purified from seminal fluid by different methods: Comparison by amino acid analysis and assigned extinction coefficients Prostate 27 1995 198 203
19. 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer Cancer Res 51 1991 222 226